DESLORATADINE ZENTIVA 0.5 mg/ml, oral solution bottle, 150 ml
Active ingredients: Desloratadine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESLORATADINE ZENTIVA 0,5 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 150 ml muni d'un bouchon sécurité enfant (propylène/PEBD) et d'une seringue pour administration orale
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Dec 2011
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66503041CIP72176269CIP133400921762693Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESLORATADINEsolution | 0,5 mg · 1 ml de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.